DSIP is not an FDA-approved medication for insomnia, sleep disorders, anxiety, recovery, or general wellness
The metabolite BH4 controls T cell proliferation in autoimmunity and cancer
Although CNS drugs may enhance TB treatment through immune modulation, their use as adjunctive therapies must be approached cautiously due to the risk of severe side effects
On July 23-24, 2026 , the FDA's Pharmacy Compounding Advisory Committee (PCAC) will convene at the FDA White Oak Campus (10903 New Hampshire Avenue, Silver Spring, MD 20993) to evaluate whether several peptides should be added to the Section 503A bulk drug substances list
The CoA should show the HPLC chromatogram or at minimum the purity percentage for the specific batch
In the UK, between 10 and 30% of the population are believed to suffer with low levels of vitamin B-12